• Skip to main content
  • Skip to footer

Cellatrix

  • HOME
  • CONCEPT
  • PRODUCTS
  • SERVICE TO PHARMA

3D tissue-engineered bone marrow

December 20, 2015 By Cellatrix

de la Puente P, Muz B, Gilson RC, Azab F, Luderer M, King J, Achilefu S, Vij R, Azab AK. 3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma. Biomaterials. 2015 Dec;73:70-84.

http://www.sciencedirect.com/science/article/pii/S0142961215007620

3D tissue engineered bone marrow (3DTEBM) cultures derived from the BM supernatant of multiple myeloma (MM) patients to incorporate different BM components were developed and characterized. 3DTEBM cultures allowed proliferation of MM cells, recapitulated their interaction with the microenvironment, recreated 3D aspects observed in the bone marrow niche (such as oxygen and drug gradients), and induced drug resistance in MM cells more than 2D or commercial 3D tissue culture systems. 3DTEBM cultures not only provide a better model for investigating the pathophysiology of MM, but also serve as a tool for drug development and screening in MM.

Filed Under: News

Footer

About Us

Cellatrix LLC is a biotechnology company in Saint Louis, Missouri. Its mission is focused on the development of science, research involving both basic and translational approaches, and drug development for the ultimate goal of patient care.

Partnership

Cellatrix is in partnership with:
  • Azab Lab/ Washington University in St. Louis
  • Biogenerator
More information

Contact Us

Cellatrix LLC
4320 Forest Park Ave, Suite 303
St Louis, MO 63108, USA
Email
314-740-1870
News & Publications

Copyright © 2023 Cellatrix.com · Powered by NeuConcept · Log in